Guliamov M G
Zh Nevropatol Psikhiatr Im S S Korsakova. 1982;82(11):115-22.
The results of evaluating the therapeutic efficacy of the new psychotropic drugs adepren, didepil, anq tempalgin made by the "Farmakhim" plant (the People's Republic of Bulgaria) are presented. Clinical trials revealed new facts that allowed to expand the scope of the indications for use formulated in the "Farmakhim" recommendations. It was found that Adepren could be used with success (in addition to the indications suggested by "Farmakhim") in the treatment of patients with depressive-paranoid paroxysms of periodic schizophrenia taking its course in the presence of general depression, as well as patients with somatogenic lingering astheno-depressive states. The therapeutic efficacy of didepil (an antiepileptic) was found to be in a direct relationship with the disease duration, character of the attacks, presence or absence of epileptic chandes of personality. The effect was the best in cases of a short duration of the disease and absence of gross epileptic personality changes, when the paroxysmal disorders were confined mostly to grand mals. A new scheme for arresting the epileptic status with didepil solution is offered. For the first time the efficacy of tempalgin in the treatment of patients suffering from alcoholic abstinence syndrome was substantiated. Optimal doses of the drugs have been determined with regard to the disease nosology and the leading syndrome. Contraindications to the use of the drugs have also been formulated.
本文介绍了对保加利亚人民共和国“法玛希姆”工厂生产的新型精神药物阿地普伦、双苯丙胺、安克替尔平治疗效果的评估结果。临床试验揭示了一些新情况,这些情况使“法玛希姆”建议中规定的用药适应症范围得以扩大。研究发现,阿地普伦除了可用于“法玛希姆”建议的适应症外,还可成功用于治疗伴有全身抑郁的周期性精神分裂症抑郁 - 偏执发作患者以及躯体源性迁延性衰弱抑郁状态患者。双苯丙胺(一种抗癫痫药)的治疗效果与病程、发作特征、是否存在癫痫性人格改变直接相关。在病程短且无明显癫痫性人格改变、发作性障碍主要为大发作的情况下,效果最佳。本文提出了一种用双苯丙胺溶液控制癫痫持续状态的新方案。首次证实了替尔平在治疗酒精戒断综合征患者方面的疗效。已根据疾病分类学和主要综合征确定了药物的最佳剂量。还制定了药物使用的禁忌症。